Software

Ended Purchase Order Awarded Last action

Contract number
75N91024P00254
Awardee
Awarding agency
Obligated
$24,776

Award facts

Contract value 100% obligated
$24,775.60 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
513210 Software Publishers
PSC
7A21 It And Telecom - Business Application Software (Perpetual License Software)
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Broomfield, CO 80021, USA

Award details come from SAM.gov/FPDS.

About this award

Visiopharm Corporation, a foreign-owned for-profit organization, was awarded a $24,775.60 firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health's National Cancer Institute to deliver software with a completion date of February 14, 2025. The award was made on February 15, 2024 without a set-aside designation. Visiopharm will provide its precision pathology software for research and diagnostics, leveraging over 20 years of experience developing artificial intelligence and deep learning solutions for digital pathology. Headquartered in Denmark, Visiopharm is the wholly owned subsidiary of Visiopharm A/S, a manufacturer of goods and provider of digital pathology solutions.

Quick answers

Who was awarded contract 75N91024P00254?

75N91024P00254 was awarded to Visiopharm Corporation by National Cancer Institute (National Institutes of Health) on February 15, 2024.

How much is contract 75N91024P00254 worth?

The government has obligated $24,776 on 75N91024P00254.

Was contract 75N91024P00254 competed?

The extent of competition for 75N91024P00254 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award